919.9500 13.60 (1.50%)
NSE Oct 07, 2025 15:06 PM
Volume: 82,515
 

919.95
1.50%
Axis Direct
Q2FY18 revenue declined 10% YoY, while EBITDA margin improved 250 bps YoY at 22.7% led by lower other expenses (-29% YoY) on lower promotion expenses in India business.
Alembic Pharmaceutic.. has an average target of 1001.00 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended